- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Governments around the world are considering how to regulate synthetic biology in an effort to maximize the benefits of the emerging technology while minimizing the risks.
But it is crucial for any governance of the technology to address the concepts of "scientific uncertainty" and "cross-borderness," according to a new working paper from the London School of Economics and Political Science's Centre for the Study of Bioscience, Biomedicine, Biotechnology and Society (BIOS).
The authors of the paper, The Transnational Governance of Synthetic Biology: Scientific Uncertainty, Cross-Borderness and the ‘Art' of Governance, argue that the implications of synthetic biology are "not only difficult to predict but are fundamentally unknowable." Further, they stress the concept of cross-borderness -- the need for strong inter-relations between geopolitical regions, academics disciplines and industrial sectors.
To best consider these concepts, the authors recommend a "flexible and evolving ‘art of governance'" for synthetic biology, which would allow for communication between key actors and ensure that stakeholders are able to express their perspectives. The authors base their conclusions on an extensive literature review and work in the United Kingdom, China and Japan.
Join us at the Woodrow Wilson International Center for Scholars on March 27 for a discussion with Dr. Claire Marris, a senior research fellow at King's College London and one of the report's authors, about the findings and their implications for the governance of synthetic biology.
Read more about the BIOS report and to download a copy here:
You must register to attend the event.
Visit [www.wilsoncenter.org/event/rsvp?eid=22807&pid=116] to RSVP
What: The Art of Synthetic Biology Governance: Considering the Concepts of Scientific Uncertainty and Cross-Borderness
When: March 27, 2012 from 12:30 p.m. - 2:00 p.m. (Light lunch available at noon.)
Who: Dr. Claire Marris, King's College London
David Rejeski, Director, Science and Technology Innovation Program, will moderate the session
Where: Woodrow Wilson International Center for Scholars
5th Floor Conference Room
Ronald Reagan Building
1300 Pennsylvania Ave NW
For directions, visit: www.wilsoncenter.org/directions
To learn more about the Synthetic Biology Project, visit: www.synbioproject.org/about/
For more information, please click here
Copyright © The Woodrow Wilson International Center for ScholarsIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017
Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017
In-cell molecular sieve from protein crystal February 14th, 2017
Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016
Argon is not the 'dope' for metallic hydrogen March 24th, 2017